KHTRF Stock UPDATES Knight Therapeutics (KHTRF) 4.9760 09/05/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Knight Therapeutics (KHTRF) 4.9760 $KHTRF

Knight Therapeutics Inc. Acquires Orphan Canada Inc. and Expands Business Development Capacity
Marketwire - Tue Sep 02, 7:33AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has entered into an asset purchase agreement with Orphan Canada Inc. ("Orphan" related to the Canadian rights for ATryn(R) and PHOTOFRIN(R) (porfimer sodium), two innovative pharmaceutical products approved for sale in multiple jurisdictions. Orphan is a privately-held, Toronto-based specialty pharmaceutical company that in-licenses therapies for rare disorders and specialty medicines for the Canadian market.

Knight Expands Team
Marketwire - Tue Aug 26, 7:04AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" announced today (1) the appointment of Amal Khouri to the position of Vice President of Business Development and (2) the appointment of Sylvie Tendler to Knight's Board of Directors. "Both Amal and Sylvie are proven pharmaceutical executives and expand our capacity to secure the rights to innovative pharmaceuticals that improve the health of Canadians", said Jonathan Ross Goodman, President and CEO of Knight.

Knight Reports Second Quarter 2014 Results
Marketwire - Thu Aug 14, 5:01AM CDT
Knight Therapeutics Inc. ("Knight" (TSX: GUD) today reported its financial results for the quarter ended June 30, 2014.

Knight Therapeutics Inc. Hires Advisor to Sell Its Priority Review Voucher
Marketwire - Tue Aug 12, 7:04AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has entered into an arrangement with a global investment banking firm to sell its neglected tropical disease Priority Review Voucher ("PRV" . The arrangement is effective August 18, 2014.

Medicure Acquires Minority Position in Pharmaceutical Manufacturer, Apicore
Marketwire - Thu Jul 03, 7:38AM CDT
Medicure Inc. ("Medicure" or the "Company" (TSX VENTURE: MPH)(OTCQB: MCUJF), a specialty pharmaceutical company, today announced that the Company and its newly formed and wholly owned subsidiary, Medicure U.S.A. Inc. ("Medicure USA" have entered into an arrangement whereby they have acquired a minority interest in a pharmaceutical manufacturing business. Specifically, Medicure and Medicure USA have acquired a 6.09% equity interest (5.33% on a fully-diluted basis) (the "Ownership Interest" in two newly formed holding companies of which Apicore LLC and Apicore US LLC (collectively, "Apicore" will be wholly owned operating subsidiaries. Medicure also received an option to acquire all of the remaining issued shares of Apicore LLC and the holding company of Apicore US LLC, within the next 3 years. The Ownership Interest and certain other rights, including the Option Rights described below, were obtained by Medicure for its lead role in structuring a US$22.5 million, majority interest purchase and financing of Apicore (the "Purchase" by Signet Healthcare Partners ("Signet" , Knight Therapeutics Inc. (TSX: GUD) ("Knight" , and investors affiliated with Sanders Morris Harris Inc. ("Sanders" (collectively, the "Investors" .

Knight Therapeutics Inc. Signs Secured Debt Financing Agreement to Support the Acquisition of Apicore
Marketwire - Thu Jul 03, 7:21AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has entered into a secured debt agreement to support the acquisition of two newly formed holding companies of which Apicore LLC and Apicore US LLC (collectively, "Apicore" will be wholly owned operating subsidiaries. The purchase arrangement included a secured loan provided by Knight and Sanders Morris Harris Inc., and an equity investment by Signet Healthcare Partners ("Signet" for an aggregate amount of US$22.5 million. Medicure Inc. ("Medicure" acquired a minority interest in Apicore and the founding shareholders of Apicore continue to own a significant minority interest in Apicore.

Knight Therapeutics Inc. Invests in Sectoral Asset Management Inc. for Preferred Access to Canadian Product Rights
Marketwire - Thu Jun 26, 7:03AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has entered into a letter of agreement with Sectoral Asset Management Inc. ("Sectoral" to invest USD$13 million into its New Emerging Medical Opportunities Funds II, Ltd. ("NEMO II" .

Knight Therapeutics Inc. and Origin Biomed Inc. Sign Secured Debt Financing Agreement
Marketwire - Wed Jun 25, 8:32AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has entered into a secured debt agreement with privately-held Origin Biomed Inc. ("Origin" , a company dedicated to the worldwide commercialization of the Neuragen(R) and Bionica brands.

Knight Therapeutics to Present at the Bloom Burton & Co. Healthcare Investor Conference in Toronto
Marketwire - Wed Jun 18, 1:29AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that Mr. Jonathan Ross Goodman, President & CEO, is scheduled to present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference on Wednesday June 18, 2014 at 11:30 am ET at the Toronto Board of Trade. A copy of the presentation will be available at www.gud-knight.com.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

JumpCloud Tackles Compliance in the AI Era

Updated Category News Views 131

Compliance in a Changing Tech Landscape JumpCloud's stepping up in this brave new world riddled with tech and AI agents. They've got fresh platform features in their arsenal that'll keep organizations audit-ready day in and day out. Now, if you think compliance is just for the accountants to fret over, think again. In the agentic era, these advanced marvels—AI agents...

Continue Reading
Study Reveals Stark Disparities in Education Equity

Updated Category News Views 5

Are We Dropping the Ball on Future Talent? Listen, there’s a harsh truth screaming at us from the NWEA’s latest study, and it’s not pretty. We’re talking about a serious gap here, folks—one that shows lower-income kids are getting the short end of the stick in education yet again. When more than half of U.S. students come from lower-income families but only 20%...

Continue Reading
2026 Global Ocean Forum Unveils Key Marine Strategies

Updated Category News Views 34

Riding the Waves in Qingdao It ain't every day that a talk-fest dedicated to oceans gets my attention, but when the Global Ocean Development Forum plants its flag in Qingdao, even I sit up. We're talking about some real fireworks in the marine economy sector with this gig's '1+1+4+8' framework. Now, before you scratch your head on the bingo numbers—it's the opening...

Continue Reading
Quad Sees Marginal Gains Amid Industry Challenges

Updated Category News Views 63

Treading Water with a Splash of Strategic Moves When you're in the thick of market shifts, sometimes it's not about big leaps but staying afloat with purpose. That's what Quad's recent financial release seems to hint at. A steady net sales figure hovering at $587 million for Q3 2026, barely a nudge compared to last year's numbers, sets the tone. It's not the fireworks...

Continue Reading
Federal Signal Acquires GVS, Boosts Vacuum Truck Lineup

Updated Category News Views 46

Federal Signal's Latest Move in Vacuum Truck Arena A shakeup in the vacuum truck market? You bet. Federal Signal Corporation has made waves yet again by acquiring the lion's share of Global Vacuum Systems (GVS) assets and operations. We're talking a transaction valued at a hefty $29 million. Dishing Out the Dollars and Cents Now, what stirs the pot in this deal is the...

Continue Reading
Personalized Senior Living Guidance Finds Home in South Jersey

Updated Category News Views 66

Shaunique Adams and Her Mission in South Jersey In a world where compassion sometimes feels like it's on short supply, Shaunique Adams is making sure it's at the forefront of her mission. Having experienced the emotional whirlwind of caregiving firsthand, Adams has transformed her personal journey into a mission to serve families navigating similar paths. Through Trua...

Continue Reading
Civitas Boosts Orlando Luxury Hotel with $386M Loan

Updated Category News Views 33

Orlando Sets the Stage for Luxury Expansion Well, it seems Orlando's hospitality scene is about to get a significant bump. Civitas Capital Group just tossed a cool $386 million into the pot for the construction of a 700-key luxury hotel on the infamous International Drive. We're not talking about just another hotel here; this one's a real beast, a future InterContinental...

Continue Reading
Nikon Unveils Game-Changing Zoom Lens for Pros

Updated Category News Views 35

Nikon Raises the Bar with New Pro Zoom Lens Well, Nikon's done it again, folks. They've dropped the NIKKOR Z 120-300mm f/2.8 TC VR S lens, and it looks like they're giving photographers something to drool over. Now, before you start rolling your eyes, this isn't just another shiny gadget. This bad boy is lighter and faster than anything Nikon's thrown at us before, and it...

Continue Reading
E. Coli Outbreaks Spark Push for New Petting Zoo Laws

Updated Category News Views 0

A Long-Standing Question Finally Answered There comes a time when asking the same question repeatedly feels like chasing your own tail. That's where Bill Marler, food safety attorney extraordinaire, found himself after two decades of wondering if petting zoos should face the chopping block. Right on the heels of E. coli investigations across Illinois, California, and...

Continue Reading
Savvas Launches Miller & Levine Biology Program Revamp

Updated Category News Views 35

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Neuboron Medical Group Sets the Stage for Cancer Treatment Innovation

Updated Category News Views 208

Introduction to Neuboron Medical Group's Innovations Neuboron Medical Group is at the forefront of revolutionizing cancer treatment through its advanced use of Boron Neutron Capture Therapy (BNCT). This technology has gained momentum worldwide, and Neuboron is making significant strides with the creation of China's first accelerator-based BNCT demonstration center in...

Continue Reading
European Market Update: Mixed Results in French Trading Session

Updated Category News Views 141

As the trading session wrapped up in France, it was clear: the stock market painted a pretty chaotic picture. The CAC 40 index took a hit, dropping by 2.00%. Meanwhile, the SBF 120 index managed to climb a bit, up by 0.66%. This kind of mixed performance suggests investors were split—some panicking while others sniffed out opportunities in the mayhem. CAC 40 Drama: Top...

Continue Reading
Man Group Reports Key Position Details in Darktrace Acquisition

Updated Category News Views 105

Man Group’s Position Disclosure Regarding Darktrace Man Group PLC has recently published a notable disclosure concerning its interests in Darktrace plc, which has sparked interest among investors and market analysts. This move complies with Rule 8.3 of the Takeover Code, which requires transparency about positions in relevant securities. Let’s take a closer look at...

Continue Reading
Apollo's Strategic Fund Closure Signals Confidence in Credit Markets

Updated Category News Views 238

Apollo's Strategic Fund Closure Signals Confidence in Credit Markets In a bold move that reflects confidence in the evolving financial landscape, Apollo recently closed on $8.5 billion in total commitments for its Accord+ strategy. This remarkable achievement includes a significant $4.8 billion earmarked for the Accord+ Fund II, demonstrating not only robust investor...

Continue Reading
Perseus Mining's Bold Move to Purchase Predictive Discovery

Updated Category News Views 231

Perseus Mining Makes a Strategic Move with Predictive Discovery Perseus Mining Limited (ASX/TSX: PRU) has announced an exciting proposal to acquire Predictive Discovery Limited (ASX: PDI), a bold step that highlights its commitment to growth in the mining sector. This proposed acquisition involves a definitive binding offer for all issued shares in Predictive Discovery...

Continue Reading